Strategic partnership Public cancer care leader with strong research and education focus, actively collaborating with universities and researchers, presenting ongoing partnership opportunities for joint programs, funded projects, and tech-enabled care initiatives.

Innovation opportunities Active engagement in cutting-edge cancer research and AI-driven drug discovery collaborations, offering potential for co-development, data-sharing arrangements, and enterprise software or analytics tools tailored to oncology.

Scale and reach Australia’s only public health service dedicated to cancer care with multiple sites and a large workforce, presenting cross-site procurement, standardization opportunities, and enterprise solutions for hospital operations, imaging, and radiation therapy services.

Funding and grants Recent grant activity and high research intensity indicate openness to funded research tools, grant-ready solutions, and pilots that align with mesothelioma, imaging, radiation therapy, and translational research needs.

Clinical and data insights Large pool of clinicians and researchers generating clinical and genomic data, suggesting opportunities for data analytics platforms, clinical decision support, imaging analytics, and secure data integration with existing tech stack.